Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein, Thierry Fest, Cynthia Harris, Seth M. Steinberg, Elaine S. Jaffe, and Mark Raffeld Blood Volume 89(2):601-609 January 15, 1997 ©1997 by American Society of Hematology

Wyndham H. Wilson et al. Blood 1997;89:601-609 ©1997 by American Society of Hematology

Wyndham H. Wilson et al. Blood 1997;89:601-609 ©1997 by American Society of Hematology

Scatter plot showing the distribution of tumor proliferation among tumor samples showing bcl-2 expression levels of 0, 1, 2, and 3. Scatter plot showing the distribution of tumor proliferation among tumor samples showing bcl-2 expression levels of 0, 1, 2, and 3. Each point represents an individual patient tumor sample. Bars represent the median within each group (P 2 = .009). Wyndham H. Wilson et al. Blood 1997;89:601-609 ©1997 by American Society of Hematology